Roche axes 1000 jobs, closes Nutley, exits inflammation
14:17 EDT 26 Jun 2012 | SCRIP
Following an audit of its R&D activities, Roche has decided to exit inflammation and small molecule oncology programmes while redirecting its cancer biologics research to Penzberg, Germany, and its virology programmes to Basel,.....
Original Article: Roche axes 1000 jobs, closes Nutley, exits inflammation
More From BioPortfolio on "Roche axes 1000 jobs, closes Nutley, exits inflammation"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
